Huveaux PLC
23 August 2005
23 August 2005
Epic Group plc ('Epic' or the 'Company')
Re: Directorate Change
Following the announcement on 22 August 2005 that the recommended offer for the
Company by Huveaux PLC ('Huveaux') had been declared wholly unconditional, John
Gordon, Donald Clark, Stephen Oliver, Ian Ritchie and Brian Stevens have
resigned as directors of Epic.
On 22 August 2005, John Philip de Blocq van Kuffeler (aged 56), Gerry Murray
(aged 52) and David Bowen Horne (aged 43), all directors of Huveaux, were each
appointed as directors of Epic.
Past and present directorship details for the new Directors are as follows:
Mr van Kuffeler
Present directorships:
Huveaux PLC and various of its subsidiary companies (Dod's Parliamentary
Communications Limited; Fenman Limited; Training Journal Limited; Mislex (420)
Limited; Vacher Dod Publishing Limited; VDP Limited)
Provident Financial PLC
Finsbury Smaller Companies Trust Plc (which was the subject of a members'
voluntary winding up, and a liquidator was appointed on 17 December 1999)
JPMorgan Fleming Technology Trust PLC (which was the subject of a members'
voluntary winding up, and a liquidator was appointed on 10 January 2003)
Past directorships in last five years (and date of cessation):
Eidos plc (17 May 2005)
Finsbury Smaller Quoted Companies Trust PLC (22 April 2003)
The Medical Defence Union Limited (21 September 2004)
MDU Investments Limited (21 September 2004)
Van Kuffeler & Company Limited (23 September 2003)
MDU Services Limited (21 September 2004)
Lancashire & London Finance Company Limited (16 April 2001)
TV Eye Limited (5 April 2005)
Mr Murray
Present directorships:
Huveaux PLC and Fenman Limited (a subsidiary of Huveaux PLC)
Virtual Reality Centre Limited
Mr Horne
Present directorships:
Huveaux PLC and various of its subsidiary companies (Dod's Parliamentary
Communications Limited; Fenman Limited; Training Journal Limited; Mislex (420)
Limited; Vacher Dod Publishing Limited; VDP Limited; Huveaux France SAS ;
European Parliamentary Communications SPRL)
Bowen Business Consultants Limited
Past directorships:
BSMG Worldwide Europe Limited*
BSMG Medical & Health Communications Limited*
Charles Barker plc*
Charles Barker Healthcare Limited*
Charles Barker Publishing Limited*
GJW Holdings Limited*
GJW Government Relations Limited*
GJW Europe Limited*
GJW International Limited*
GJW Scotland Limited*
Mediphacs Limited *
Square Mile Holdings Limited*
Square Mile Communications Limited*
Square Mile Research Limited*
The Three Castles' Trial Limited (ceased to be director on 1 March 2003)
* Ceased to be a director on 31 December 2001
Save as disclosed in this announcement, Messrs van Kuffeler, Murray and Horne
have each confirmed that there are no further disclosures required on their
behalf pursuant to paragraph (g) of Schedule 2 of the AIM Rules.
Contact:
John van Kuffeler, Director Tel: 020-7245-0270
Stephen Oliver, Company Secretary Tel: 01236 728 686
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.